- Home
- NCTY vs ANEB Comparison
NCTY vs ANEB Comparison
Compare NCTY & ANEB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NCTY
- ANEB
- Stock Information
- Founded
- NCTY 1999
- ANEB 2020
- Country
- NCTY China
- ANEB United States
- Employees
- NCTY N/A
- ANEB N/A
- Industry
- NCTY Business Services
- ANEB Biotechnology: Pharmaceutical Preparations
- Sector
- NCTY Consumer Discretionary
- ANEB Health Care
- Exchange
- NCTY Nasdaq
- ANEB Nasdaq
- Market Cap
- NCTY 121.2M
- ANEB 117.1M
- IPO Year
- NCTY 2004
- ANEB 2021
- Fundamental
- Price
- NCTY $7.54
- ANEB $2.50
- Analyst Decision
- NCTY
- ANEB Buy
- Analyst Count
- NCTY 0
- ANEB 2
- Target Price
- NCTY N/A
- ANEB $8.00
- AVG Volume (30 Days)
- NCTY 36.9K
- ANEB 1.2M
- Earning Date
- NCTY 01-01-0001
- ANEB 09-24-2025
- Dividend Yield
- NCTY N/A
- ANEB N/A
- EPS Growth
- NCTY N/A
- ANEB N/A
- EPS
- NCTY N/A
- ANEB N/A
- Revenue
- NCTY $15,305,175.00
- ANEB N/A
- Revenue This Year
- NCTY N/A
- ANEB N/A
- Revenue Next Year
- NCTY N/A
- ANEB N/A
- P/E Ratio
- NCTY N/A
- ANEB N/A
- Revenue Growth
- NCTY N/A
- ANEB N/A
- 52 Week Low
- NCTY $6.28
- ANEB $0.80
- 52 Week High
- NCTY $20.59
- ANEB $3.42
- Technical
- Relative Strength Index (RSI)
- NCTY 36.34
- ANEB 55.36
- Support Level
- NCTY $7.41
- ANEB $2.22
- Resistance Level
- NCTY $8.42
- ANEB $2.66
- Average True Range (ATR)
- NCTY 0.62
- ANEB 0.20
- MACD
- NCTY -0.12
- ANEB -0.08
- Stochastic Oscillator
- NCTY 6.70
- ANEB 28.78
About NCTY The9 Limited American Depository Shares
The9 Ltd operates a cryptocurrency mining business. It provides computing power, or hash rate, to a Bitcoin mining pool and is entitled to receive a fractional share of Bitcoin award from the Bitcoin mining pool in return. The company generates its revenues from customers in Greater China, Asia/Eastern Europe, and North America. Its segments are: Crypto mining business, and Other, out of which Crypto mining business derives maximum revenue.
About ANEB Anebulo Pharmaceuticals Inc.
Anebulo Pharmaceuticals Inc is a clinical-stage biotechnology company, developing novel solutions for people suffering from cannabinoid overdose and substance addiction. The product candidate, ANEB-001, is intended to reverse the negative effects of cannabinoid overdose within 1 hour of administration. The signs and symptoms of cannabinoid overdose range from profound sedation to anxiety and panic to psychosis with hallucinations.